1. Home
  2. VRAX vs LDWY Comparison

VRAX vs LDWY Comparison

Compare VRAX & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • LDWY
  • Stock Information
  • Founded
  • VRAX 2013
  • LDWY 1990
  • Country
  • VRAX United Kingdom
  • LDWY United States
  • Employees
  • VRAX N/A
  • LDWY N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • LDWY Advertising
  • Sector
  • VRAX Health Care
  • LDWY Consumer Discretionary
  • Exchange
  • VRAX Nasdaq
  • LDWY Nasdaq
  • Market Cap
  • VRAX 7.3M
  • LDWY 8.2M
  • IPO Year
  • VRAX 2022
  • LDWY 1991
  • Fundamental
  • Price
  • VRAX $1.89
  • LDWY $4.25
  • Analyst Decision
  • VRAX
  • LDWY
  • Analyst Count
  • VRAX 0
  • LDWY 0
  • Target Price
  • VRAX N/A
  • LDWY N/A
  • AVG Volume (30 Days)
  • VRAX 289.0K
  • LDWY 4.5K
  • Earning Date
  • VRAX 02-05-2025
  • LDWY 03-31-2025
  • Dividend Yield
  • VRAX N/A
  • LDWY N/A
  • EPS Growth
  • VRAX N/A
  • LDWY N/A
  • EPS
  • VRAX N/A
  • LDWY N/A
  • Revenue
  • VRAX $84,872.00
  • LDWY $31,581,000.00
  • Revenue This Year
  • VRAX $5,169.18
  • LDWY N/A
  • Revenue Next Year
  • VRAX $66.97
  • LDWY N/A
  • P/E Ratio
  • VRAX N/A
  • LDWY N/A
  • Revenue Growth
  • VRAX 7.03
  • LDWY N/A
  • 52 Week Low
  • VRAX $0.60
  • LDWY $3.02
  • 52 Week High
  • VRAX $9.00
  • LDWY $6.88
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 48.72
  • LDWY 47.81
  • Support Level
  • VRAX $1.58
  • LDWY $4.13
  • Resistance Level
  • VRAX $2.29
  • LDWY $4.55
  • Average True Range (ATR)
  • VRAX 0.23
  • LDWY 0.22
  • MACD
  • VRAX -0.02
  • LDWY -0.02
  • Stochastic Oscillator
  • VRAX 45.95
  • LDWY 39.98

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About LDWY Lendway Inc. (DE)

Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two Industry Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.

Share on Social Networks: